In this study, we demonstrated that the activation of AKT plays a major role in triggering EMT in colon cancer cells, suggesting that targeting AKT signaling could lead to the inhibition of EMT and ultimately less invasive cancer. The gene discussed is AKT1; the disease is malignant colon neoplasm.